Menu Search
Equities

Quest Diagnostics Inc

QDI:BER

Quest Diagnostics Inc

Actions
  • Price (EUR)144.80
  • Today's Change0.70 / 0.49%
  • Shares traded--
  • 1 Year change+16.68%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 07:04 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. The Company also focuses on artificial intelligence (AI) and digital pathology solutions for biopharmaceutical companies and pathology laboratories. It has implemented AI, digital and automation technologies across several laboratory and business functions.

  • Revenue in USD (TTM)9.54bn
  • Net income in USD838.00m
  • Incorporated1996
  • Employees40.00k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		DGX:NYQ since
announced		Transaction
value
Lifelabs IncDeal completed03 Jul 202403 Jul 2024Deal completed16.63%987.13m
Lenco Diagnostic Laboratories IncDeal completed01 Feb 202401 Feb 2024Deal completed24.09%111.00m
Steward Health Care System LLC-Outreach Laboratory Services Business Select AssetsDeal completed08 Jan 202408 Jan 2024Deal completed12.25%--
Data delayed at least 15 minutes, as of Nov 09 2024.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.